Artículos relacionados a Real-World Evidence in Drug Development and Evaluation...
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series) - Tapa blanda
Sinopsis
Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field.
Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions.
Features
- Provides the first book and a single source of information on RWE in drug development
- Covers a broad array of topics on outcomes- and value-based RWE assessments
- Demonstrates proper Bayesian application and causal inference for real-world data (RWD)
- Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insights
- Offers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise
"Sinopsis" puede pertenecer a otra edición de este libro.
Acerca del autor
Harry Yang, Ph.D., is Vice President and Head of Biometrics at Fate Therapeutics. He has 25 years of experience across all aspects of drug research and development, from early target discovery, through pre-clinical, clinical, and CMC programs to regulatory approval and post-approval lifecycle management. He has published 7 statistical books, 15 book chapters, and over 90 peer-reviewed papers on diverse scientific and statistical subjects. He is a frequent invited speaker at national and international conferences. He also developed statistical courses and conducted training at the FDA and USP.
Binbing Yu, Ph.D., is Associate Director in the Oncology Statistical Innovation group at AstraZeneca. He serves as the statistical expert across the whole spectrum of drug R&D, including drug discovery, clinical trials, operation and manufacturing, clinical pharmacology, oncology medical affairs and post-marketing surveillance. He obtained his PhD in Statistics from the George Washington University. His primary research interests are clinical trial design and analysis, cancer epidemiology, causal inference in observation studies, PKPD modeling and Bayesian analysis.
"Sobre este título" puede pertenecer a otra edición de este libro.
- EditorialChapman and Hall/CRC
- Año de publicación2022
- ISBN 10 0367637014
- ISBN 13 9780367637019
- EncuadernaciónTapa blanda
- IdiomaInglés
- Número de edición1
- Número de páginas190
- EditorYang Harry, Yu Binbing
- Contacto del fabricanteno disponible
EUR 59,80
EUR 17,34 gastos de envío desde Estados Unidos de America a España
Destinos, gastos y plazos de envíoComprar nuevo
Ver este artículo
EUR 60,90
EUR 5,24 gastos de envío desde Reino Unido a España
Destinos, gastos y plazos de envío
Resultados de la búsqueda para Real-World Evidence in Drug Development and Evaluation...
Imagen de archivo
Real-World Evidence in Drug Development and Evaluation
Publicado por
Taylor & Francis Ltd, 2022
ISBN 10: 0367637014
ISBN 13: 9780367637019
Nuevo
Paperback / softback
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Paperback / softback. Condición: New. New copy - Usually dispatched within 4 working days. 185. Nº de ref. del artículo: B9780367637019
Cantidad disponible: 1 disponibles
Imagen del vendedor
Real-World Evidence in Drug Development and Evaluation
Publicado por
Taylor & Francis Ltd Aug 2022, 2022
ISBN 10: 0367637014
ISBN 13: 9780367637019
Nuevo
Taschenbuch
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Calificación del vendedor: 5 de 5 estrellas
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field.Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions.FeaturesProvides the first book and a single source of information on RWE in drug developmentCovers a broad array of topics on outcomes- and value-based RWE assessments Demonstrates proper Bayesian application and causal inference for real-world data (RWD)Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insightsOffers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise 178 pp. Englisch. Nº de ref. del artículo: 9780367637019
Cantidad disponible: 2 disponibles
Imagen de archivo
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
Publicado por
Chapman and Hall/CRC, 2022
ISBN 10: 0367637014
ISBN 13: 9780367637019
Nuevo
Tapa blanda
Librería: Majestic Books, Hounslow, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Nº de ref. del artículo: 401655685
Cantidad disponible: 3 disponibles
Imagen del vendedor
Real-World Evidence in Drug Development and Evaluation
Impresión bajo demandaLibrería: moluna, Greven, Alemania
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Harry Yang, Ph.D., is Vice President and Head of Biometrics at Fate Therapeutics. He has 25 years of experience across all aspects of drug research and development, from early target discovery, through pre-clinical, clinical, and CMC pro. Nº de ref. del artículo: 842314163
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
Publicado por
Chapman and Hall/CRC, 2022
ISBN 10: 0367637014
ISBN 13: 9780367637019
Nuevo
Tapa blanda
Librería: California Books, Miami, FL, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Nº de ref. del artículo: I-9780367637019
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
Publicado por
Chapman and Hall/CRC, 2022
ISBN 10: 0367637014
ISBN 13: 9780367637019
Nuevo
Tapa blanda
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: New. In. Nº de ref. del artículo: ria9780367637019_new
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Real-world Evidence in Drug Development and Evaluation
Publicado por
Chapman and Hall/CRC, 2022
ISBN 10: 0367637014
ISBN 13: 9780367637019
Antiguo o usado
Tapa blanda
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Condición: As New. Unread book in perfect condition. Nº de ref. del artículo: 44651855
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Real-World Evidence in Drug Development and Evaluation
Impresión bajo demandaLibrería: PBShop.store UK, Fairford, GLOS, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
PAP. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Nº de ref. del artículo: L0-9780367637019
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Real-World Evidence in Drug Development and Evaluation
Impresión bajo demandaLibrería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
PAP. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Nº de ref. del artículo: L0-9780367637019
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Real-world Evidence in Drug Development and Evaluation
Impresión bajo demandaLibrería: Revaluation Books, Exeter, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Paperback. Condición: Brand New. 178 pages. 9.18x6.12x0.43 inches. In Stock. This item is printed on demand. Nº de ref. del artículo: __0367637014
Cantidad disponible: 1 disponibles